These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8505561)

  • 21. [Staphylococcus aureus resistant to cloxacillin: treatment with fosfomycin-rifampicin].
    Wolff M; Nercelles P; Pepay K
    Rev Med Chil; 1984 Jul; 112(7):665-71. PubMed ID: 6569621
    [No Abstract]   [Full Text] [Related]  

  • 22. Activity of antibiotics against Staphylococcus aureus within polymorphonuclear neutrophils.
    Yancey RJ; Sanchez MS; Ford CW
    Eur J Clin Microbiol Infect Dis; 1991 Feb; 10(2):107-13. PubMed ID: 1864272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [In vivo bactericidal activity of an oxacillin-netilmicin combination against Staphylococcus aureus. Influence of the rhythm of netilmicin administration].
    Weber M; Voiriot P; Dopff C; Tronel H; Melet M; Dureux JB
    Pathol Biol (Paris); 1988 May; 36(5):389-93. PubMed ID: 3043334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In-vitro activity and killing effect of quinupristin/dalfopristin (RP59500) on nosocomial Staphylococcus aureus and interactions with rifampicin and ciprofloxacin against methicillin-resistant isolates.
    Sambatakou H; Giamarellos-Bourboulis EJ; Grecka P; Chryssouli Z; Giamarellou H
    J Antimicrob Chemother; 1998 Mar; 41(3):349-55. PubMed ID: 9578161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro and in vivo synergistic activities of linezolid combined with subinhibitory concentrations of imipenem against methicillin-resistant Staphylococcus aureus.
    Jacqueline C; Navas D; Batard E; Miegeville AF; Le Mabecque V; Kergueris MF; Bugnon D; Potel G; Caillon J
    Antimicrob Agents Chemother; 2005 Jan; 49(1):45-51. PubMed ID: 15616274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro and in vivo effects of combinations of cefotaxime or other beta-lactams with rolitetracycline on methicillin-resistant Staphylococcus aureus.
    Kobayashi S; Arai S; Hayashi S
    Jpn J Antibiot; 1989 May; 42(5):1208-15. PubMed ID: 2746860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microbiological indications for the treatment of Staphylococcus aureus infections.
    Fabbri A; Tacchella A; Belli ML; Losurdo G
    Chemioterapia; 1988 Dec; 7(6):378-81. PubMed ID: 3219748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Sensitivity of methicillin resistant staphylococci to linezolid and some other antimicrobial agents].
    Ertek M; Yazgi H; Aktaş E; Ayyildiz A; Parlak M
    Mikrobiyol Bul; 2003 Oct; 37(4):235-40. PubMed ID: 14748259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A mouse peritonitis model for the study of glycopeptide efficacy in GISA infections.
    Domenech A; Ribes S; Cabellos C; Domínguez MA; Montero A; Liñares J; Ariza J; Gudiol F
    Microb Drug Resist; 2004; 10(4):346-53. PubMed ID: 15650381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rifampicin-containing combinations are superior to combinations of vancomycin, linezolid and daptomycin against Staphylococcus aureus biofilm infection in vivo and in vitro.
    Jørgensen NP; Skovdal SM; Meyer RL; Dagnæs-Hansen F; Fuursted K; Petersen E
    Pathog Dis; 2016 Jun; 74(4):ftw019. PubMed ID: 27036412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of tolerance in cloxacillin treatment of experimental Staphylococcus aureus endocarditis.
    Voorn GP; Thompson J; Goessens WH; Schmal-Bauer W; Broeders PH; Michel MF
    J Infect Dis; 1991 Mar; 163(3):640-3. PubMed ID: 1995736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro evaluation of clindamycin in combination with oxacillin, rifampin, or vancomycin against Staphylococcus aureus.
    Ho JL; Klempner MS
    Diagn Microbiol Infect Dis; 1986 Feb; 4(2):133-8. PubMed ID: 3956136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activity of netilmicin against clinical isolates of methicillin resistant and susceptible Staphylococcus aureus.
    Manoharan A; Lalitha MK; Jesudason MV
    Natl Med J India; 1997; 10(2):61-2. PubMed ID: 9153980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Therapeutic effect of some antibiotics on experimental staphylococcal infection and its correlation with in vitro activity of antibiotics in sub-inhibitory concentration against Staphylococcus aureus strains].
    Kaczmarska L; Jakoniuk P
    Med Dosw Mikrobiol; 2003; 55(1):1-10. PubMed ID: 12908409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Netilmicin and netilmicin-rifampicin combination in targeted treatment of staphylococcal infections].
    Andreoni M; Picchini G; Ricciardiello P
    Clin Ter; 1986 Sep; 118(5):333-8. PubMed ID: 3757469
    [No Abstract]   [Full Text] [Related]  

  • 36. In vitro activity of recombinant lysostaphin-antibiotic combinations toward methicillin-resistant Staphylococcus aureus.
    Polak J; Della Latta P; Blackburn P
    Diagn Microbiol Infect Dis; 1993; 17(4):265-70. PubMed ID: 8112040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intracellular antimicrobial activity appearing as a relevant factor in antibiotic efficacy against an experimental foreign-body infection caused by Staphylococcus aureus.
    Murillo O; Pachón ME; Euba G; Verdaguer R; Carreras M; Cabellos C; Cabo J; Gudiol F; Ariza J
    J Antimicrob Chemother; 2009 Nov; 64(5):1062-6. PubMed ID: 19744977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The anti-biofilm effect of macrolides in a rat model of S. aureus foreign-body infection: Might it be of clinical relevance?
    El Haj C; Murillo O; Ribera A; Garcia-Somoza D; Tubau F; Cabellos C; Cabo J; Ariza J
    Med Microbiol Immunol; 2017 Feb; 206(1):31-39. PubMed ID: 27639707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experimental study on the efficacy of combinations of glycopeptides and beta-lactams against Staphylococcus aureus with reduced susceptibility to glycopeptides.
    Domenech A; Ribes S; Cabellos C; Taberner F; Tubau F; Domínguez MA; Montero A; Liñares J; Ariza J; Gudiol F
    J Antimicrob Chemother; 2005 Oct; 56(4):709-16. PubMed ID: 16120625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determination of antimicrobial susceptibility patterns in Staphylococcus aureus strains recovered from patients at two main health facilities in Kabul, Afghanistan.
    Naimi HM; Rasekh H; Noori AZ; Bahaduri MA
    BMC Infect Dis; 2017 Nov; 17(1):737. PubMed ID: 29187146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.